OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - SYNTHETIC BIOLOGICS INC ownership

SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U102. A total of 59 filers reported holding SYNTHETIC BIOLOGICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of SYNTHETIC BIOLOGICS INC
ValueSharesWeighting
Q2 2017$424,000,000
-32.8%
749,848
-25.0%
0.01%
-36.4%
Q1 2017$631,000,000
-17.3%
1,000,0000.0%0.01%
-26.7%
Q4 2016$763,000,0001,000,0000.02%
Other shareholders
SYNTHETIC BIOLOGICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,998,941$5,839,0002.81%
Knoll Capital Management, LLC 3,400,816$4,965,0001.95%
Third Security, LLC 12,300,768$17,960,0000.82%
MSD Partners, L.P. 3,583,500$5,232,0000.12%
Genesis Wealth Advisors, LLC 35,000$78,750,0000.06%
THOMPSON DAVIS & CO., INC. 20,000$29,0000.03%
TFS CAPITAL LLC 157,800$230,0000.02%
HAMILTON LANE ADVISORS LLC 23,855$35,0000.01%
WEDBUSH SECURITIES INC 12,000$18,0000.00%
REGIONS FINANCIAL CORP 100,000$146,0000.00%
View complete list of SYNTHETIC BIOLOGICS INC shareholders